Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
12.15
-0.40 (-3.19%)
At close: Mar 28, 2025, 4:00 PM
12.53
+0.38 (3.16%)
After-hours: Mar 28, 2025, 7:59 PM EDT
Nurix Therapeutics Analyst Ratings
Total Analysts
17
Consensus Rating
Strong Buy
Price Target
$30.82
Upside
+153.66%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Leerink Partners | Leerink Partners | Hold Initiates $16 | Hold | Initiates | $16 | +31.69% | Mar 17, 2025 |
Morgan Stanley | Morgan Stanley | Hold Maintains $16 → $17 | Hold | Maintains | $16 → $17 | +39.92% | Feb 3, 2025 |
RBC Capital | RBC Capital | Buy Maintains $26 → $27 | Buy | Maintains | $26 → $27 | +122.22% | Jan 29, 2025 |
JP Morgan | JP Morgan | Buy Maintains $31 → $30 | Buy | Maintains | $31 → $30 | +146.91% | Jan 29, 2025 |
Stifel | Stifel | Strong Buy Maintains $34 → $36 | Strong Buy | Maintains | $34 → $36 | +196.30% | Jan 29, 2025 |
Needham | Needham | Strong Buy Maintains $29 → $28 | Strong Buy | Maintains | $29 → $28 | +130.45% | Jan 29, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $35 → $36 | Strong Buy | Maintains | $35 → $36 | +196.30% | Jan 29, 2025 |
Stephens & Co. | Stephens & Co. | Buy Reiterates $31 | Buy | Reiterates | $31 | +155.14% | Jan 21, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $35 | Strong Buy | Maintains | $30 → $35 | +188.07% | Dec 11, 2024 |
BTIG | BTIG | Strong Buy Initiates $35 | Strong Buy | Initiates | $35 | +188.07% | Dec 10, 2024 |
Needham | Needham | Strong Buy Reiterates $29 | Strong Buy | Reiterates | $29 | +138.68% | Dec 10, 2024 |
BMO Capital | BMO Capital | Buy Initiates $35 | Buy | Initiates | $35 | +188.07% | Dec 6, 2024 |
Needham | Needham | Strong Buy Reiterates $29 | Strong Buy | Reiterates | $29 | +138.68% | Nov 6, 2024 |
UBS | UBS | Strong Buy Initiates $35 | Strong Buy | Initiates | $35 | +188.07% | Oct 24, 2024 |
Needham | Needham | Strong Buy Reiterates $29 | Strong Buy | Reiterates | $29 | +138.68% | Oct 21, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $26 → $30 | Strong Buy | Maintains | $26 → $30 | +146.91% | Oct 21, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.